This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Study Type
OBSERVATIONAL
Enrollment
1,000
Novolimus-eluting stent
Hallym Hospital
Incheon, South Korea
RECRUITINGAsan Medical Hospital
Seoul, South Korea
RECRUITINGKorea University Guro Hospital
Seoul, South Korea
Composite event rate
Death, non-fatal myocardial infarction, Target Vessel Revascularization
Time frame: 1year
All death
Time frame: 5years
Cardiac death
Time frame: 5years
Myocardial infarction
Time frame: 5years
Composite event of death or myocardial infarction
Time frame: 5years
Composite event of cardiac death or myocardial infarction
Time frame: 5years
Target Vessel revascularization
Time frame: 5years
Target Lesion revascularization
Time frame: 5years
Stent thrombosis
stent thrombosis as classified by an Academic Research Consortium
Time frame: 5years
Stroke
Time frame: 5years
Procedural success
defined as achievement of a final diameter stenosis of \<30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization.
Time frame: 3days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
WITHDRAWNThe Catholic University of Korea, Eunpyeong St. Mary's Hospital
Seoul, South Korea
TERMINATEDSt.carollo Hospital
Suncheon, South Korea
TERMINATED